Epidermoid anal cancer prognosis comparison among HIV+ and HIV- patients

Alimentary Pharmacology and Therapeutics

Volumn 30, Issue 4, 2009, Pages 414-421

  Abramowitz, L ^a   Mathieu, N ^a   Roudot Thoraval, F ^b   Lemarchand, N ^c   Bauer, P ^d   Hennequin, C ^e   Mitry, E ^b   Romelaer, C ^c   Aparicio, T ^a   Sobhani, I ^f  

^a BICHAT HOSPITAL   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c Léopold Bellan Hospital   (France)

^d GROUPE HOSPITALIER DIACONESSES CROIX SAINT SIMON   (France)

^e SAINT LOUIS HOSPITAL   (France)

^f HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CISPLATIN; FLUOROURACIL; FOLINIC ACID;

ADULT; ANUS CARCINOMA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE DURATION; DISEASE FREE SURVIVAL; DOSE RESPONSE; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TREATMENT PLANNING; VIRUS LOAD;

ADULT; AGE FACTORS; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEX FACTORS; STATISTICS AS TOPIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 67651176284     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2009.04026.x     Document Type: Article

References (20)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin 2000 50 : 7 33.
2. Uronis HE, Bendell JC. Anal cancer: an overview. Oncologist 2007 12 : 524 34.
3. Frisch M, Glimelius B, van den Brule AJ, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997 337 : 1350 8.
4. Melbye M, Rabkin C, Frisch M, Biggar RJ. Changing patterns of anal cancer incidence in the United States, 1940-1989. Am J Epidemiol 1994 139 : 772 80.
5. Sobhani I, Walker F, Roudot-Thoraval F, et al. Anal carcinoma: incidence and effect of cumulative infections. AIDS 2004 18 : 1561 9.
6. Sobhani I, Vuagnat A, Walker F, et al. Prevalence of high-grade dysplasia and cancer in the anal canal in human papillomavirus-infected individuals. Gastroenterology 2001 120 : 857 66.
7. Sobhani I, Walker F, Aparicio T, et al. Effect of anal epidermoid cancer-related viruses on the dendritic (Langerhans') cells of the human anal mucosa. Clin Cancer Res 2002 8 : 2862 9.
8. Vatra B, Sobhani I, Aparicio T, et al. Anal canal squamous-cell carcinomas in HIV positive patients: clinical features, treatments and prognosis. Gastroenterol Clin Biol 2002 26 : 150 6.
9. Kim JH, Sarani B, Orkin BA, et al. HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV- patients. Dis Colon Rectum 2001 44 : 1496 502.
10. Goldman S, Norming U, Svensson C, Glimelius B. Transanorectal ultrasonography in the staging of anal epidermoid carcinoma. Int J Colorectal Dis 1991 6 : 152 7.
11. Abramowitz L, Benabderrahmane D, Ravaud P, et al. Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: prevalence and associated factors. AIDS 2007 21 : 1457 65.
12. Piketty C, Darragh TM, Da Costa M, et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med 2003 138 : 453 9.
13. Ryan DP, Compton CC, Mayer RJ. Carcinoma of the anal canal. N Engl J Med 2000 342 : 792 800.
14. Wexler A, Berson AM, Goldstone SE, et al. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy. Dis Colon Rectum 2008 51 : 73 81.
15. Hessol NA, Pipkin S, Schwarcz S, Cress RD, Bacchetti P, Scheer S. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. Am J Epidemiol 2007 165 : 1143 53.
16. Oehler-Janne C, Huguet F, Provencher S, et al. HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy. J Clin Oncol 2008 26 : 2550 7.
17. Berretta M, Cinelli R, Martellotta F, Spina M, Vaccher E, Tirelli U. Therapeutic approaches to AIDS-related malignancies. Oncogene 2003 22 : 6646 59.
18. Ajani JA, Winter KA, Gunderson LL, et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 2008 299 : 1914 21.
19. Edelman S, Johnstone PA. Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities. Int J Radiat Oncol Biol Phys 2006 66 : 206 11.
20. Place RJ, Gregorcyk SG, Huber PJ, Simmang CL. Outcome analysis of HIV-positive patients with anal squamous cell carcinoma. Dis Colon Rectum 2001 44 : 506 12.